Clinical Trial of Integrated Treatment for Pain and Opioid Dependence

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to develop an effective psychotherapy for chronic pain and opioid dependence.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yale University
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Analgesics, Opioid; Buprenorphine

Criteria

Inclusion Criteria:

• 18 years of age or older

• prescription opioid addiction criteria

• moderate to severe chronic pain

• seeking or interested in buprenorphine maintenance

• understand English

Exclusion Criteria:

• methadone maintenance at a dose greater than 40 mg daily

• current suicide or homicide risk

• life-threatening or unstable medical problem

• pregnancy